Jump to content

SMTP support for LabVIEW


Recommended Posts

Hi all,

I was not successful in running the SMTP example provided for PDA Mobile by NI,though I used the same POP and SMTP settings to send mail through my native e-mail client(mobile).

I got following error message from E-Mail server:

"553 Sorry, that domain isn't in my list of allowed rcpthosts."

Listing the arbitration between PDA SMTP VI and e-mail server.

Message to server :

  1. HELO 10.20.5.32
  2. MAIL FROM:<info@goflexteq.com>
  3. RCPT TO:<info@goflexteq.com>
  4. DATA
  5. To: info@goflexteq.com
    From: info@goflexteq.com
    Subject: Project details Test.
  6. QUIT

Response from Server:

  1. 220 smtpauth02.prod.mesa1.secureserver.net ESMTP.
  2. 250 smtpauth02.prod.mesa1.secureserver.net.
  3. 250 Sender accepted.
  4. 553 Sorry, that domain isn't in my list of allowed rcpthosts.

I would really appreciate if any of you could interpret this arbitration and let me know what the issue is.

Thanks in advance,

Manu Mohan

Link to comment
  • 4 weeks later...

Most likely the problem is that your native mail client supports authentication, while the NI example does not. When using authenticated SMTP the mail server is willing to accept mail to any destination because it knows who the sender is and that you have permission to use it. Without that authentication the mail server will only accept mail for a limited set of addresses (most likely only mailboxes in that domain) because otherwise spammers will use it to relay mail.

Link to comment

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.